Reliable Quality

Affordable Innovation

Name Indication Clinical Trial Phase Study Title
HLX10+HLX07
Head and Neck Squamous Cell Carcinoma
phase II Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors
HLX10+HLX07
Squamous Non-small-cell Lung Cancer
phase II A Randomized, Open-Label, Multicenter, Phase II Study of HLX07 (Anti-EGFR Antibody) In Combination With HLX10 (Anti-PD-1 Antibody) With or Without Chemotherapy Versus HLX10 With Chemotherapy in First Line Recurrent or Metastatic Squamous Non-Small Cell Lung Cancer.
HLX10+HLX07
Soild Tumours
phase II
HLX14
Healthy Male Volunteers
Phase I

Pharmacokinetic, Safety and Immunogenicity Phase I Study of HLX14 Versus Prolia® in Healthy Male Subjects

HLX10 + chemotherapy
Cervical Cancer
phase II

A Clinical Study to Evaluate Efficacy and Safety of HLX10 Combined With Albumin-Bound Paclitaxel in Patients With Advanced Cervical Cancer Who Have Progressive Disease or Intolerable Toxicity After First-Line Standard Chemotherapy